|
| Press Releases |
|
 |
|
| Tuesday, September 6, 2022 |
|
|
Oculis announces publication of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema |
| Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the Phase 2 DX-211, a randomized, double blinded, multi-center and vehicle controlled clinical trial assessing the safety and efficacy of topical OCS-01 in patients with Diabetic Macular Edema (DME) (NCT05343156) has been published by the Acta Ophthalmologica journal. more info >> |
|
| Tuesday, August 23, 2022 |
|
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease |
| Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the results of the double blinded more info >> |
|
| Wednesday, June 29, 2022 |
|
|
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery |
| Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations more info >> |
|
| Wednesday, March 2, 2022 |
|
|
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics |
| Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company more info >> |
|
| Tuesday, February 8, 2022 |
|
|
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer |
| Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the further strengthening of the Company's executive leadership team with the appointment of Dr. Bastian Dehmel as global Chief Development Officer more info >> |
|
| Wednesday, January 5, 2022 |
|
|
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) |
| Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the appointment of Mr. Webb Ding as global Chief Operating Officer and General Manager, China, with effect from February 1, 2022. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST
|
|
|
Elevate Your Sleep Game This World Health Day with LAC 
Apr 25, 2024 09:00 HKT/SGT
|
|
|
UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 9:00 JST
|
|
|
GA-ASI Selected to Build CCA for AFLCMC
Apr 25, 2024 07:00 HKT/SGT
|
|
|
The South China Sea: A Nuanced Understanding Required
Apr 24, 2024 21:12 HKT/SGT
|
|
|
Kontent.ai Introduces Mission Control and New Brand Identity, Leading a New Era of Content Management
Apr 24, 2024 20:51 HKT/SGT
|
|
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
Apr 24, 2024 18:59 HKT/SGT
|
|
|
Legacy Credit Emerges as a Substantial Shareholder in VCI Global
Apr 24, 2024 18:00 HKT/SGT
|
|
|
Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date
Apr 24, 2024 17:19 JST
|
|
|
MC and Denka Sign J/V Agreement in Fullerene Business
Apr 24, 2024 17:02 JST
|
|
|
Mitsubishi Motors Posts Record Sales in the Philippines in FY2023
Apr 24, 2024 13:56 JST
|
|
|
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
Apr 24, 2024 13:25 JST
|
|
|
Dogs Thrive on Vegan Diets, Demonstrates the Most Comprehensive Study So Far
Apr 24, 2024 07:00 HKT/SGT
|
|
|
Graid Technology Announces Software Update, Delivers Enhanced Levels of Data Integrity and Business Continuity
Apr 23, 2024 23:00 HKT/SGT
|
|
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Apr 23, 2024 22:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
